Cargando…
Usefulness and real-world outcomes of next generation sequencing testing in patients with cancer: an observational study on the impact of selection based on clinical judgement
BACKGROUND: Next Generation Sequencing (NGS) panels are increasingly used in advanced patients with cancer to guide therapy. There is, however, controversy about when should these panels be used, and about their impact on the clinical course. METHODS: In an observational study of 139 patients with c...
Autores principales: | Colomer, Ramon, Miranda, Jesús, Romero-Laorden, Nuria, Hornedo, Javier, González-Cortijo, Lucía, Mouron, Silvana, Bueno, Maria J., Mondéjar, Rebeca, Quintela-Fandino, Miguel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248077/ https://www.ncbi.nlm.nih.gov/pubmed/37304496 http://dx.doi.org/10.1016/j.eclinm.2023.102029 |
Ejemplares similares
-
When should we order a next generation sequencing test in a patient with cancer?
por: Colomer, Ramon, et al.
Publicado: (2020) -
Nintedanib plus letrozole in early breast cancer: a phase 0/I pharmacodynamic, pharmacokinetic, and safety clinical trial of combined FGFR1 and aromatase inhibition
por: Quintela-Fandino, Miguel, et al.
Publicado: (2019) -
Personalising and targeting antiangiogenic resistance: a complex and multifactorial approach
por: Bueno, Maria J, et al.
Publicado: (2017) -
Monitoring vascular normalization: new opportunities for mitochondrial inhibitors in breast cancer
por: Mouron, Silvana, et al.
Publicado: (2021) -
FGFR1 amplification or overexpression and hormonal resistance in luminal breast cancer: rationale for a triple blockade of ER, CDK4/6, and FGFR1
por: Mouron, Silvana, et al.
Publicado: (2021)